Exhibition · Zurich, Switzerland
Molecular Analysis for Personalised Therapy
Biotechnology · Medicine
Key numbers
- Editions on record
- 1first in 2017
About Molecular Analysis for Personalised Therapy
A joint initiative of Cancer Research UK, UNICANCER and ESMO, this conference will explore clinical interpretation of molecular tests for metastatic cancers. The development of new biotechnologies has revolutionised the applications of personalised therapy in metastatic cancer. It is now possible to perform multigene sequencing for cancer patients, either in clinical trials, or in routine use. Unfortunately, while the technologies are robust, the interpretations of these molecular analyses is still a matter of debate, and there is a need to understand which molecular alterations should be targeted in cancer patients.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 13–14 Oct 2017 | Swissôtel Zurich Zurich, Switzerland | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Molecular Analysis for Personalised Therapy?
The next dates haven't been confirmed. The last edition we have on record was 13–14 Oct 2017.
Where is it held?
The last edition we have was at Swissôtel Zurich, Zurich, Switzerland.